-
Artificial pancreas app for type 1 diabetes patients launched after University of Cambridge research
An artificial pancreas app that enables insulin to be delivered automatically to people with type 1 diabetes was launched on Monday. The world-first downloadable licensed app, CamAPS FX, follows 13 years of research by Professor Roman Hovorka at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. A…
-
First-of-its-Kind Bio-Artificial Pancreas on Track for Type-I Diabetes Cure
Leading biomedical company Beta-O2 Technologies gearing up to start second round of human clinical trials within the year on heels of promising preliminary results Boston, MA — Imagine a world where those living with Type 1 Diabetes, a chronic illness affecting more than 60 million adults globally, no longer had…
-
Israeli artificial pancreas may one day cure diabetes
Ahead of International Diabetes Day, November 14, Israeli startup Betalin Therapeutics announced that it is beginning the application process for clinical trials of its revolutionary artificial pancreas. Betalin’s Engineered Micro Pancreas (EMP) aims to free patients suffering from the most severe types of diabetes from constantly monitoring blood-sugar levels and…
-
AI could be the key to catching Type 1 diabetes much earlier
Will AI lead to a quicker diagnosis of diabetes, a condition often called the silent killer? IBM researchers are hoping so. They recently announced an AI-powered screening tool that could potentially identify Type 1 diabetes antibodies in people’s blood. For the millions of people who live with Type 1 diabetes…
-
NIH Funds First Artificial Pancreas Study in the United States for Pregnant Women
The National Institutes of Health has awarded a R01 grant to a multi-institutional team to develop and evaluate a pregnancy-specific Artificial Pancreas in a sequence of in-clinic and transitional environment clinical trials. The researchers hope that the first-in-the-nation studies will lead to a safe and effective at-home clinical trial with…
-
Stem Cell Therapies Advancements
2 different articles about Stem Cells… SERAXIS Inc. publishes clinical trial considerations for a type 1 diabetes stem cell-derived therapy … continue here Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas … continue here
-
Klue Expands Artificial Intelligence Platform with Offering for Type 1 Diabetes
SAN FRANCISCO — Klue, a digital health company focused on behavior tracking and positive change, announces its platform’s expansion to Type 1 Diabetes (T1D). Klue is already known for its gesture sensing and analytics technology that promotes mindful eating and proper hydration. Now, it is ready to branch out in…
